There are some limitations in drug delivery of α-MG in oral cancer prevention and treatment including thickness of keratinization tissues of the oral mucosa, which may influence drug permeability into the OPMD lesions. This evidence concerns the gene AMELX and oculopharyngeal muscular dystrophy.